We are almost there ...
Pfizer wants a slice of the weight-loss pie
The drugmaker announces plans to start clinical trials of a formulation that will give it a shot at a space dominated by Eli Lilly and Novo Nordisk’s blockbuster offerings.
11 July, 2024•2 min
0
11 July, 2024•2 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
SEBI increases FPI disclosure threshold to Rs 50,000 crore
The regulator is also planning to set up a committee to review the conflict of interest and disclosure provisions for its members.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.